These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7145994)

  • 1. Methyl-GAG in advanced renal cell carcinoma.
    Child JA
    Prog Clin Biol Res; 1982; 100():663-7. PubMed ID: 7145994
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
    Williams PD; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):153-61. PubMed ID: 6844733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
    Knight WA; Drelichman A; Fabian C; Bukowski RM
    Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
    Thongprasert S; Bosl GJ; Geller NL; Wittes RE
    Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
    Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
    Yap HY; Blumenschein GR; Schell F; Bodey GP
    Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer.
    Child JA; Bono AV; Fossa SD; Ten Bokkel Huinink WW; De Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):85-7. PubMed ID: 7200896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels and urinary excretion of methyl-GAG following iv infusion in man.
    Marsh KC; Liesmann J; Patton TF; Fabian CJ; Sternson LA
    Cancer Treat Rep; 1981; 65(3-4):253-7. PubMed ID: 7237449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
    Levi JA; Wiernik PH
    Cancer Chemother Rep; 1975; 59(5):1043-5. PubMed ID: 54215
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group.
    Knight WA; O'Bryan RM; Samal B; Costanzi JJ
    Invest New Drugs; 1984; 2(1):71-3. PubMed ID: 6469501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
    Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA
    Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.
    Scher HI; Yagoda A; Ahmed T; Watson RC
    J Clin Oncol; 1985 Feb; 3(2):224-8. PubMed ID: 3968552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
    Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF
    Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.